The Venture Codex Logo

The Venture Codex

Overview

Accelerating development of high-quality antibacterial products.

Founded

2016

Deals · 12mo

0

Stage focus

Grant

Geographic focus

Australia
Denmark
India
Spain
...

Sector focus

—

Investment portfolio

16rounds
NAMEDATESIZE
Centauri Therapeutics
Jul 2025Led
$5 MOther Equity
Visby Medical
Jan 2025Led
$4 MGrant
Vedanta Biosciences
Oct 2024Led
$4 MOther Equity
SNIPR Biome
Apr 2024Led
$5 MOther Equity
Visby Medical
Feb 2024Led
$2 MGrant
GangaGen
Aug 2023Led
$2 MGrant
Day Zero Diagnostics
Oct 2022Led
$8 MOther Equity
Clarametyx Biosciences
Apr 2022Led
$4 MGrant
SpeeDx
May 2021Led
$2 MOther Equity
Vaxdyn
Mar 2021Participated
$1 MOther Equity
Clarametyx Biosciences
Nov 2020Led
$14 MOther Equity
Spexis
Oct 2020Led
$3 MOther Equity
Centauri Therapeutics
Jul 2025Led
$5 MOther Equity
Visby Medical
Jan 2025Led
$4 MGrant
Vedanta Biosciences
Oct 2024Led
$4 MOther Equity
SNIPR Biome
Apr 2024Led
$5 MOther Equity
Visby Medical
Feb 2024Led
$2 MGrant
GangaGen
Aug 2023Led
$2 MGrant
Day Zero Diagnostics
Oct 2022Led
$8 MOther Equity
Clarametyx Biosciences
Apr 2022Led
$4 MGrant
SpeeDx
May 2021Led
$2 MOther Equity
Vaxdyn
Mar 2021Participated
$1 MOther Equity
Clarametyx Biosciences
Nov 2020Led
$14 MOther Equity
Spexis
Oct 2020Led
$3 MOther Equity
16
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

CARB-X: 16 funding rounds are recorded in the selected participation categories.All available history.
CARB-X: 16 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Other Equity91
Grant60

Monthly Deal Activity

CARB-X: 16 deals are recorded across 108 months.All available history.
CARB-X: 16 deals are recorded across 108 months. All available history
MonthDeals
Nov '171
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '191
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '191
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '201
Jul '200
Aug '200
Sep '200
Oct '201
Nov '201
Dec '200
Jan '210
Feb '210
Mar '211
Apr '210
May '211
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '221
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '221
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '231
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '241
Mar '240
Apr '241
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '241
Nov '240
Dec '240
Jan '251
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '251
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

CARB-X: Health & Life Sciences is the largest displayed sector by deal count (16 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

CARB-X: Health & Life Sciences is the largest displayed sector by deal count (16 deals). All available history
SectorDeals
Health & Life Sciences16
Professional Services3
Space & Frontier Tech1

Deal Size Distribution

CARB-X: 16 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

CARB-X: 16 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M9
$5M-$10M5
$10M-$25M2
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

CARB-X: United States has the largest recorded deal count among the displayed regions (9 deals).All available history.

Top 4 of 4 regions; European countries are grouped as Europe.

CARB-X: United States has the largest recorded deal count among the displayed regions (9 deals). All available history
RegionDeals
United States9
Europe4
India2
Australia1
CARB-X: 3 co-investors are shown, with Arquimea Group sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

CARB-X: 3 co-investors are shown, with Arquimea Group sharing 1 recorded deals. All available history
Co-investorShared deals
Arquimea Group1
Bionova Capital1
Botin Foundation1

Investment Strategy

CARB-X: Led accounts for 94% and participating for 6% of round participation.All available history.
CARB-X: Led accounts for 94% and participating for 6% of round participation. All available history
CategoryDeals (count)Share (%)
Led1594%
Participating16%
CARB-X: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
CARB-X: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead15100%
Co-led00%

Team

Diane MacDonald

Chief Operating Officer

Kevin Outterson

Executive Director

Richard Alm

Chief Scientific Officer